We are live on ! Find out more
ISEE

IVERIC bio, Inc. Common Stock
ISEE

Delisted

ISEE was delisted on the 10th of July, 2023.

Back to rankings

115 hedge funds and large institutions have $495M invested in IVERIC bio, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 45 increasing their positions, 29 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

134% more call options, than puts

Call options by funds: $5.48M | Put options by funds: $2.34M

55% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 29

4% less funds holding

Funds holding: 120 → 115 (-5)

9% less capital invested

Capital invested by funds: $542M → $495M (-$46.5M)

31% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 16

50% less funds holding in top 10

Funds holding in top 10: 6 → 3 (-3)

Holders
115
Holders Change
-5
Holders Change %
-4.17%
% of All Funds
2.02%
Holding in Top 10
3
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-50%
% of All Funds
0.05%
New
11
Increased
45
Reduced
29
Closed
16
Calls
$5.48M
Puts
$2.34M
Net Calls
+$3.14M
Net Calls Change
-$3.62M

Top Buyers

1
YCM
Yiheng Capital Management
California
+$15.9M
2
SCM
Soleus Capital Management
Connecticut
+$10.8M
3
LGM
Logos Global Management
California
+$7.28M
4
CC
Commodore Capital
New York
+$2.76M
5
ACP
Acuta Capital Partners
California
+$2.23M

Top Sellers

1
CCM
Consonance Capital Management
New York
-$16.4M
2
Citadel Advisors
Citadel Advisors
Florida
-$10.6M
3
BCM
Burrage Capital Management
Massachusetts
-$9.59M
4
FCM
Farallon Capital Management
California
-$5.21M
5
Goldman Sachs
Goldman Sachs
New York
-$4.31M
Name Holding Trade Value Shares
Change 		Change in
Stake
ACA
1
Avoro Capital Advisors
New York
$44.8M – – –
BlackRock
2
BlackRock
New York
$43.6M +$1.79M +295,366 +4%
RI
3
RTW Investments
New York
$41.5M – – –
VC
4
Vivo Capital
California
$36.9M – – –
DM
5
Deerfield Management
New York
$35.6M – – –
PA
6
Perceptive Advisors
New York
$28.3M +$624K +102,799 +2%
Vanguard Group
7
Vanguard Group
Pennsylvania
$26.1M +$374K +61,671 +1%
State Street
8
State Street
Massachusetts
$22.8M +$1.7M +279,711 +8%
SCM
9
Soleus Capital Management
Connecticut
$20.9M +$10.8M +1,783,700 +112%
YCM
10
Yiheng Capital Management
California
$17.2M +$15.9M +2,626,407 +1,666%
FM
11
Frazier Management
Washington
$15.7M +$304K +50,000 +2%
SB
12
Samsara BioCapital
California
$14.7M – – –
T. Rowe Price Associates
13
T. Rowe Price Associates
Maryland
$13.4M +$57.8K +9,520 +0.4%
CC
14
Commodore Capital
New York
$10.7M +$2.76M +454,780 +36%
ACP
15
Acuta Capital Partners
California
$9.76M +$2.23M +366,593 +30%
BBA
16
Baker Bros. Advisors
New York
$8.69M – – –
Geode Capital Management
17
Geode Capital Management
Massachusetts
$8.25M +$1.13M +186,427 +16%
LGM
18
Logos Global Management
California
$7.42M +$7.28M +1,200,000 New
GTC
19
Ghost Tree Capital
New York
$6.95M -$1.52M -250,000 -18%
Ameriprise
20
Ameriprise
Minnesota
$6.61M +$1.58M +259,830 +32%
ACM
21
Altium Capital Management
New York
$5.58M – – –
Citadel Advisors
22
Citadel Advisors
Florida
$5.54M -$10.6M -1,739,384 -66%
SCM
23
Stonepine Capital Management
Oregon
$5.41M +$456K +75,180 +9%
Millennium Management
24
Millennium Management
New York
$5.11M +$130K +21,387 +3%
Northern Trust
25
Northern Trust
Illinois
$5.04M -$308K -50,816 -6%
1
2 3 4 5

ISEE Hedge Fund Activity: Q1 2021 in Review

115 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in IVERIC bio, Inc. Common Stock (ISEE) for Q1 2021, worth a combined $495M — down 8.6% from $542M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of ISEE and 11 opened new positions — a net loss of 5 holders — while 29 trimmed existing stakes and 45 added.

The largest buyer was Yiheng Capital Management, adding an estimated $15.9M. The largest seller was Consonance Capital Management, exiting entirely with an estimated $16.4M sold.

  • 115 institutional investors held IVERIC bio, Inc. Common Stock (ISEE) as of Q1 2021, down from 120 in Q4 2020.
  • Funds reported $495M of IVERIC bio, Inc. Common Stock stock for Q1 2021, down 8.6% quarter-over-quarter.
  • 11 funds opened new IVERIC bio, Inc. Common Stock positions in Q1 2021 and 16 closed out, a net change of -5 holders.
  • The largest IVERIC bio, Inc. Common Stock buyer in Q1 2021 was Yiheng Capital Management, an estimated $15.9M added.
  • The largest IVERIC bio, Inc. Common Stock seller in Q1 2021 was Consonance Capital Management, an estimated $16.4M sold.

Based on aggregated 13F filings for Q1 2021.